NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

Analyst price target for JNJ

Based on 12 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$155.00+7.40%
Avg Forecast
$168.25+16.58%
Max Forecast
$182.00+26.11%

Should I buy or sell JNJ stock?

Strong Buy
Strong Buy
10 analysts 66.67%
Buy
1 analysts 6.67%
Hold
4 analysts 26.67%
Sell
0 analysts 0.00%
Strong Sell
0 analysts 0.00%

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
44.07%
Industry
55.93%
Market
-1.26%
JNJ's Return on Equity is forecast to be high in 4 years (44.07%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
17.52%
Industry
15.10%
Market
11.45%
JNJ is forecast to generate higher Return on Assets (17.52%) than the US Drug Manufacturers - General industry average (15.10%)
Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$7.99+38.19%
Avg 2 year Forecast
$9.02+55.98%
Avg 3 year Forecast
$9.71+67.96%
JNJ's earnings are forecast to grow at a rate of 19.22% per year, which is not exceptional
Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$81.9B+1.76%
Avg 2 year Forecast
$88.9B+10.37%
Avg 3 year Forecast
$93.3B+15.86%
JNJ's revenue is forecast to grow at a rate of 5.18% per year, which is not exceptional
Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
19.22%
Industry
20.04%
Market
14.77%
JNJ's earnings are forecast to grow slower (19.22% per year) than the US Drug Manufacturers - General industry average (20.04%)
Forecast
JNJ's earnings are forecast to grow faster (19.22% per year) than the US market average (14.77%)
Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
5.18%
Industry
6.42%
Market
5.69%
JNJ's revenues are forecast to grow slower (5.18% per year) than the US Drug Manufacturers - General industry average (6.42%)
Forecast
JNJ's revenues are forecast to grow slower (5.18% per year) than the US market average (5.69%)
Forecast

Johnson & Johnson Stock Forecast FAQ

The consensus among 15 Wall Street analysts covering (NYSE: JNJ) stock is to Strong Buy JNJ stock.

Out of 15 analysts, 10 (66.67%) are recommending JNJ as a Strong Buy, 1 (6.67%) are recommending JNJ as a Buy, 4 (26.67%) are recommending JNJ as a Hold, 0 (0.00%) are recommending JNJ as a Sell, and 0 (0.00%) are recommending JNJ as a Strong Sell.
According to 12 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $168.25, with the highest JNJ stock price forecast at $182.00 and the lowest JNJ stock price forecast at $155.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could reach $168.25 by Oct 15, 2021. The average Johnson & Johnson stock price prediction forecasts a potential upside of 16.58% from the current JNJ share price of $144.32.
(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 19.22% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 20.04%, and while it is forecast to beat the US market's average forecast earnings growth rate of 14.77%.

Johnson & Johnson's earnings in 2020 is $15,185,000,000.On average, 8 Wall Street analysts forecast JNJ's earnings for 2020 to be $21,043,823,848, with the lowest JNJ earnings forecast at $20,945,026,553, and the highest JNJ earnings forecast at $21,155,794,116. On average, 9 Wall Street analysts forecast JNJ's earnings for 2021 to be $23,752,450,490, with the lowest JNJ earnings forecast at $23,105,394,072, and the highest JNJ earnings forecast at $25,819,026,443.

In 2022, JNJ is forecast to generate $25,576,643,746 in earnings, with the lowest earnings forecast at $24,633,458,902 and the highest earnings forecast at $26,609,404,804.
(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 5.18% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 5.69%.

Johnson & Johnson's revenue in 2020 is $80,503,000,000.On average, 4 Wall Street analysts forecast JNJ's revenue for 2020 to be $215,817,216,376,588, with the lowest JNJ revenue forecast at $214,848,549,734,715, and the highest JNJ revenue forecast at $216,463,556,184,670. On average, 5 Wall Street analysts forecast JNJ's revenue for 2021 to be $234,088,572,088,694, with the lowest JNJ revenue forecast at $230,721,981,808,090, and the highest JNJ revenue forecast at $237,379,602,198,035.

In 2022, JNJ is forecast to generate $245,732,325,980,988 in revenue, with the lowest revenue forecast at $241,199,764,273,785 and the highest revenue forecast at $249,922,906,779,170.
(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $5.78. On average, analysts forecast that JNJ's EPS will be $7.99 for 2020, with the lowest EPS forecast at $7.95, and the highest EPS forecast at $8.03. On average, analysts forecast that JNJ's EPS will be $9.02 for 2021, with the lowest EPS forecast at $8.77, and the highest EPS forecast at $9.80. In 2022, JNJ's EPS is forecast to hit $9.71 (min: $9.35, max: $10.10).
(NYSE: JNJ) forecast ROE is 44.07%, which is considered strong.
(NYSE: JNJ) forecast ROA is 17.52%, which is higher than the forecast US Drug Manufacturers - General industry average of 15.10%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics